Onos, ROMVIMZA

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | boerse | 67928573 |